Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (41-50 of 556) with videos related to

Pageof 56
Sort By:
Leukemia Research|August 8, 2016
Precision medicine in acute myeloid leukemia: Hope, hype or both?Vinay Prasad, Robert Peter Gale
Best Practice & Research. Clinical Haematology|September 7, 2025
Immune therapy of haematological cancersBin Pan, Robert Peter Gale
British Journal of Haematology|January 17, 2022
Everyone is entitled to his or her own opinion but not to their own factsGiovanni Barosi, Robert Peter Gale
Transplantation|April 27, 2016
Paul Ichiro Terasaki September 10, 1929 to January 25, 2016: Transplant PioneerRobert Peter Gale, Gerhard Opelz
Journal of Cancer Research and Clinical Oncology|April 18, 2016
Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in ChinaQian Jiang, Robert Peter Gale
Leukemia|December 9, 2025
40 years of LEUKEMIAAndreas Hochhaus, Robert Peter Gale
Leukemia|January 29, 2026
Physician-complementing artificial intelligence in haematology: ushering in a new eraJunren Chen, Robert Peter Gale
Leukemia|March 22, 2025
Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasmsRobert Peter Gale, Christophe Badie
British Journal of Haematology|November 10, 2020
Point: Is there a best duration of deep molecular response to achieve therapy-free remission in chronic myeloid leukaemia?Robert Peter Gale, Giuseppe Saglio
Leukemia Research|March 31, 2017
Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not muchRobert Peter Gale, Gerhard Opelz
Pageof 56

Showing results (41-50 of 556) with videos related to

Sort By:
Pageof 56
Leukemia Research|August 8, 2016
Precision medicine in acute myeloid leukemia: Hope, hype or both?Vinay Prasad, Robert Peter Gale
Best Practice & Research. Clinical Haematology|September 7, 2025
Immune therapy of haematological cancersBin Pan, Robert Peter Gale
British Journal of Haematology|January 17, 2022
Everyone is entitled to his or her own opinion but not to their own factsGiovanni Barosi, Robert Peter Gale
Transplantation|April 27, 2016
Paul Ichiro Terasaki September 10, 1929 to January 25, 2016: Transplant PioneerRobert Peter Gale, Gerhard Opelz
Journal of Cancer Research and Clinical Oncology|April 18, 2016
Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in ChinaQian Jiang, Robert Peter Gale
Leukemia|December 9, 2025
40 years of LEUKEMIAAndreas Hochhaus, Robert Peter Gale
Leukemia|January 29, 2026
Physician-complementing artificial intelligence in haematology: ushering in a new eraJunren Chen, Robert Peter Gale
Leukemia|March 22, 2025
Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasmsRobert Peter Gale, Christophe Badie
British Journal of Haematology|November 10, 2020
Point: Is there a best duration of deep molecular response to achieve therapy-free remission in chronic myeloid leukaemia?Robert Peter Gale, Giuseppe Saglio
Leukemia Research|March 31, 2017
Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not muchRobert Peter Gale, Gerhard Opelz
Pageof 56